INTRODUCTION9.1 As mentioned in para 1.2 of Part I of this write-up (
BCAJ May, 2022), the said Explanation to section 37(1) provides for disallowance of certain expenses. These are popularly known as illegal/prohibited expenses. As further mentioned in para 1.3 of Part I of this write-up, the MCI Regulations prohibit medical practitioners from aiding, abetting or committing any unethical acts specified in Clause 6 which, inter-alia, include receiving any gift, gratuity, commission etc. for referring, recommending or procuring of any patient for any treatment. The scope of this prohibition was expanded on 14th December, 2009 by inserting Clause 6.8 which, in substance, provided further restrictions prohibiting medical practitioners from accepting from any Pharmaceutical or Allied Health Care Industry (hereinafter referred to as Pharma Companies) any emoluments in the form of travel facility for vacation or for attending conferences/seminars, certain hospitality etc. (popularly known as freebies) referred to in para 1.4 of Part I of this write-up. The CBDT issued a Circular dated 1st August, 2012, clarifying that expenses incurred by Pharma Companies for distribution of freebies to medical practitioners violate the provisions of MCI Regulations and should be disallowed under the said Explanation to Section 37(1). The validity of this Circular was upheld by the Himachal Pradesh High Court (
Confederation of Indian Pharma Industry’s
